Stroke causes death and disability due to secondary cellular death occurring over a long period. Celle is committed to store menstrual blood and use it as a source of stem cells in neurorestorative treatments to salvage the ischemic penumbra and help the patient recover to some extent. Cell therapy, as on date, is the only promising treatment on the horizon for management of stroke and its treatment.
Ongoing research by the company has shown that menstrual blood is regenerative and non-invasive and a rich source of stem cells from the uterine lining. These stem cells are multipotent and can be segregated into adipogenic, osteogenic, neurogenic, pulmonary epithelial, hepatic, pancreatic and cardiogenic cell lineages, with a capacity for proliferation. Stem cells from renewable menstrual blood can also be a low cost option. Studies have been conducted to focus on neural stem cells for potential use in transplants for stroke therapy, helping patients regain functionality to some extent.
In order to aid collection Celle provides complete collection and shipping kits for women, helping them collect menstrual blood on the day the discharge is the highest. Collected in a uterine cup, the blood is transferred to a bag and shipped to the company headquarters where it follows a series of procedures to separate the stem cells and store them in liquid nitrogen.
No comments:
Post a Comment